Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | 67,50 € | 79,43 € | 17,67 % |
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | 732,70 € | 766,92 € | 4,67 % |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | 834,80 € | 957,22 € | 14,66 % |
| Icon plc | 18 | 0 | 6 | 0 | 279,10 € | 318,99 € | 14,29 % |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | 61,08 € | 86,77 € | 42,06 % |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | 149,32 € | 200,06 € | 33,98 % |
| Biogen Inc. | 44 | 2 | 4 | 1 | 201,40 € | 293,57 € | 45,77 % |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | 3,16 € | 11,05 € | 249,63 % |
| Abbott Laboratories | 16 | 0 | 4 | 0 | 99,29 € | 116,81 € | 17,64 % |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | 368,10 € | 382,71 € | 3,97 % |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | 41,20 € | 82,93 € | 101,29 % |
| XOMA Corp. | 6 | 0 | 3 | 0 | 23,00 € | 68,78 € | 199,04 % |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | 128,85 € | 137,63 € | 6,82 % |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | 74,54 € | 100,00 € | 34,16 % |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | 2,17 € | 4,57 € | 110,77 % |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | 57,50 € | 81,53 € | 41,79 % |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | 121,00 € | 124,93 € | 3,25 % |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | 13,82 € | 20,00 € | 44,72 % |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | 12,79 € | 27,00 € | 111,01 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 373,50 € | 421,61 € | 12,88 % |
| Amgen Inc. | 21 | 0 | 3 | 0 | 256,75 € | 294,28 € | 14,62 % |
| Geron Corp. | 11 | 0 | 3 | 0 | 3,68 € | 4,60 € | 25,01 % |
| Krystal Biotech | 16 | 0 | 3 | 0 | 145,15 € | 173,22 € | 19,34 % |
| AbbVie Inc. | 20 | 1 | 3 | 1 | 152,38 € | 174,43 € | 14,47 % |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | 75,66 € | 102,62 € | 35,63 % |